tiprankstipranks
Trending News
More News >
Verona Pharma (VRNA)
:VRNA
US Market

Verona Pharma (VRNA) Income Statement

Compare
Followers

Verona Pharma Income Statement

Last quarter (Q2 2025), Verona Pharma's total revenue was $103.14M, an increase of Infinity% from the same quarter last year. In Q2, Verona Pharma's net income was $11.92M. See Verona Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 42.28M$ 0.00$ 458.00K$ 40.00M$ 0.00
Gross Profit
$ 39.70M$ -679.62K$ 112.00K$ 40.00M$ -627.85K
Operating Expenses
$ 194.32M$ 67.15M$ 66.23M$ 97.68M$ 66.01M
Depreciation and Amortization
$ 1.06M$ 679.62K$ 636.00K$ 629.00K$ 627.85K
EBITDA
$ -142.19M$ -52.47M$ -67.29M$ -42.19M$ -47.81M
Operating Income
$ -154.63M$ -67.83M$ -66.12M$ -73.31M$ -74.28M
Other Income/Expenses
$ -8.50M$ 12.62M$ 7.30M$ -1.37M$ 6.78M
Pretax Income
$ -163.13M$ -55.21M$ -68.45M$ -55.59M$ -65.00M
Net Income
$ -173.42M$ -54.37M$ -68.70M$ -55.57M$ -65.15M
Per Share Metrics
Basic EPS
$ -2.16$ -0.72$ -1.04$ -0.96$ -2.00
Diluted EPS
$ -2.16$ -0.69$ -1.04$ -0.96$ -2.00
Weighted Average Shares Outstanding
81.54M 75.51M 66.06M 59.15M 32.87M
Weighted Average Shares Outstanding (Diluted)
81.54M 79.27M 66.13M 59.15M 32.87M
Currency in USD

Verona Pharma Earnings and Revenue History